x
Ariana Pharma
[contact-form-7 404 "Not Found"]

Ariana Pharma
  • Contact Us
  • Home
  • About Us
  • Our Business
  • Our Technology
  • Real World Data
  • News & more
    • In The News
    • Case study
    • Publications
      • Publications & Conferences
      • Whitepaper & blog
  • Careers
Logo

Contact Info

  • 58-60 Avenue de la Grande Armée, 75017, Paris, France
  • +33 1 44 37 17 00
  • info@arianapharma.com

Nov2024

Ariana reaffirms its position on drug development and publishes its new manifesto.

We all share the same challenge: finding the right therapy for the right patient. Yet, failures remain frequent, costs continue to soar and over 12,000 diseases still have no treatment. What if you reimagine your drug development process with explainable AI? A methodology where the amount of available data doesn’t matter because we go beyond traditional probability- and statistics-based approaches.
At Ariana, we collaborate with your experts to deliver results grounded in logic-based rules, ensuring our analyses meet your needs precisely—and even exceed them!

At Ariana, the depth of your data matters more than its volume

We don’t rely on the size of your data but its depth:
    • ● Work with small datasets enriched with multiple variables and descriptors
    • ● Improve data quality and expand datasets
    • ● Handle heterogeneous and incomplete data with unmatched precision
We uncover critical insights by harnessing the power of advanced analytics and logic-based frameworks.
Maximize the impact of your clinical trials by focusing on precision and innovation
  • ● Optimal dosing strategies
  • ● Surrogate, Safety, and Patient Selection Biomarkers
  • ● Enhanced trial outcomes with refined responder groups and better stratification
  • ● Integrate external real-world evidence (RWE) to create virtual control arms
Our approach uncovers hidden biomarkers within vast datasets, ensuring the best outcomes for your trials.

Anticipate regulatory challenges and address critical decision points

Our unique collaborative approach combines :
  • ● Logic-driven methodologies: Moving beyond probabilities with iterative processes involving experts, machines, and clients.
  • ● World-class expertise: Our expert and Scientific Advisory Board include international specialists across major therapeutic areas.
Maximize the true value of your assets by proving the the real-world benefits of your molecules
Our analyses help you unlock:
    • ● Optimal drug combinations
    • ● New therapeutic indications
    • ● Expedited regulatory approval strategies
At Ariana Pharma, the Future of Drug Development is Re-IMAGINED
We don’t just help you find biomarkers, we empower you to redefine your entire strategy, paving the way for sustainable success.

Categories

  • Alzheimer's
  • Autism
  • Autoimmune disease
  • Cancer
  • Fibromyalgia
  • Kidney Transplant
  • Parkinson’s
  • Precision Medicine
  • Publications
  • Real World Evidence
  • Recent Posts
  • Type A Diabetes

Tags

alzheimer's autism cancer Event Fibromyalgia Graft rejection Influenza Kidney Laboratory lung neurological Oncology Professor Jean-Yves BLAY Centre Leon berard Parkinson Parkinson’s precisionmedicine precision medicine publication realworldevidence recent post Recent Posts Research Transplant vaccine

Ariana Pharmaceuticals, The AI DRUG Development Company

  • Paris, FRANCE / Cambridge, MA, USA
  • Call Us: +33 144 37 17 00
  • info@arianapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Ariana Pharma © 2024 All Rights Reserved